Advertisement

Calcified Tissue International

, Volume 101, Issue 5, pp 473–478 | Cite as

Health-Related Quality of Life in Adults with Osteogenesis Imperfecta

  • Jannie Dahl Hald
  • Lars Folkestad
  • Torben Harsløf
  • Kim Brixen
  • Bente Langdahl
Original Research

Abstract

Osteogenesis imperfecta (OI) is a systemic connective tissue disorder most often caused by mutations in collagen type 1 related genes. Patients with OI suffer from multiple fractures and various degrees of growth deficiency and bone deformity. It is unknown whether the systemic effect of defect collagen type 1 influences the quality of life in patients with OI. We therefore aimed to investigate health-related quality of life (HRQoL) in a well-characterized cohort of adult patients with OI. We included 85 adult patients with mild to severe OI (types I, III, and IV) and obtained information about skeletal- and non-skeletal phenotypes and patient demographics. We investigated physical and mental HRQoL using a validated questionnaire, SF-36, and compared the data to values obtained in a population without OI. Patients with mild, moderate, and severe OI all had lower mean scores on domains describing physical HRQoL and a lower mean physical component score compared to the general population, p < 0.001. Patients with severe OI had lower mean scores on physical HRQoL, p < 0.05. The scores on domains reflecting mental HRQoL were more inhomogenously affected, but did not differ significantly from the general population. OI has an impact on physical and some aspects of mental HRQoL. The scores on physical health were correlated to severity of the OI disease. The mental component score in the OI patients was unaffected and comparable with the general population.

Keywords

Osteogenesis imperfecta HRQoL SF36 Physical health Mental health 

Notes

Acknowledgements

We thank Dorte Haubek and Hans Gjørup for performing dental examinations, Christer Zøylner Swan and Jens Wanscher for performing audiologic evaluations, and Christian-Heinrich Leonhard for performing eye examinations. Grant supporters: Central Region of Denmark, Osteoporoseforeningen, Denmark

Author Contributions

JDH, TH, and BL designed the study. JDH conducted the study and prepared the first draft of the paper. JDH is responsible for statistical analysis of the data. All authors contributed substantially, revised the paper critically, and approved the final version of the paper. JDH is the guarantor.

Compliance with Ethical Standards

Conflict of interest

LF reports having received speaker fees from Genzymes and AstraZeneca. TH reports having received speaker fees from Amgen. BL reports advisory board membership and having received speaking fees from Amgen, Eli Lilly, Merck, and UCB and research support from Eli Lilly, Novo Nordisk, and Orkla Health. KB reports having received grants from MSD, Novartis, Amgen, and NPS. JDH has no interests to declare.

Human and Animal Rights and Informed Consent

The study complied with ethical standards of research involving human participants and was approved by the Danish Ethical Committee (ref-number M-20100108). Informed consent was obtained from all patients.

References

  1. 1.
    Glorieux FH (2008) Osteogenesis imperfecta. Best Pract Res Clin Rheumatol 22:85–100CrossRefPubMedGoogle Scholar
  2. 2.
    Sillence DO, Senn A, Danks DM (1979) Genetic heterogeneity in osteogenesis imperfecta. J Med Genet 16:101–116CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Folkestad L, Hald JD, Ersboll AK, Gram J, Hermann AP, Langdahl B, Abrahamsen B (2016) Brixen K. A Nationwide Register-Based Cohort Study. J Bone Miner Res, Fracture Rates and Fracture Sites in Patients With Osteogenesis Imperfecta, p 10Google Scholar
  4. 4.
    van Dijk FS, Sillence DO (2014) Osteogenesis imperfecta: clinical diagnosis, nomenclature and severity assessment. Am J Med Genet A 164A:1470–1481CrossRefPubMedGoogle Scholar
  5. 5.
    Chevrel G, Meunier PJ (2001) Osteogenesis imperfecta: lifelong management is imperative and feasible. Joint Bone Spine 68:125–129CrossRefPubMedGoogle Scholar
  6. 6.
    Paterson CR, McAllion S, Stellman JL (1984) Osteogenesis imperfecta after the menopause. N Engl J Med 310:1694–1696CrossRefPubMedGoogle Scholar
  7. 7.
    Rauch F, Glorieux FH (2004) Osteogenesis imperfecta. Lancet 363:1377–1385CrossRefPubMedGoogle Scholar
  8. 8.
    Bishop NJ, Walsh JS (2014) Osteogenesis imperfecta in adults. J Clin Investig 124(2):476CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Bishop N (2010) Characterising and treating osteogenesis imperfecta. Early Hum Dev 86:743–746CrossRefPubMedGoogle Scholar
  10. 10.
    Balkefors V, Mattsson E, Pernow Y, Saaf M (2013) Functioning and quality of life in adults with mild-to-moderate osteogenesis imperfecta. Physiother Res Int 18:203–211CrossRefPubMedGoogle Scholar
  11. 11.
    Wekre LL, Froslie KF, Haugen L, Falch JA (2010) A population-based study of demographical variables and ability to perform activities of daily living in adults with osteogenesis imperfecta. Disabil Rehabil 32:579–587CrossRefPubMedGoogle Scholar
  12. 12.
    Staquet M, Hays R, Fayers P (1998) Quality of life assessment in clinical trials; methods and practice. Oxford University Press, OxfordGoogle Scholar
  13. 13.
    Widmann RF, Laplaza FJ, Bitan FD, Brooks CE, Root L (2002) Quality of life in osteogenesis imperfecta. Int Orthop 26:3–6CrossRefPubMedGoogle Scholar
  14. 14.
    Forestier-Zhang L, Watts L, Turner A, Teare H, Kaye J, Barrett J, Cooper C, Eastell R, Wordsworth P, Javaid MK, Pinedo-Villanueva R (2016) Health-related quality of life and a cost-utility simulation of adults in the UK with osteogenesis imperfecta, X-linked hypophosphatemia and fibrous dysplasia. Orphanet J Rare Dis 11:160CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    han-Oliel N, Oliel S, Tsimicalis A, Montpetit K, Rauch F, Dogba MJ (2016) Quality of life in osteogenesis imperfecta: A mixed-methods systematic review. Am J Med Genet A 170:62–76CrossRefGoogle Scholar
  16. 16.
    Widmann RF, Bitan FD, Laplaza FJ, Burke SW, DiMaio MF, Schneider R (1999) Spinal deformity, pulmonary compromise, and quality of life in osteogenesis imperfecta. Spine 24:1673–1678CrossRefPubMedGoogle Scholar
  17. 17.
    Dogba MJ, Bedos C, Durigova M, Montpetit K, Wong T, Glorieux FH, Rauch F (2013) The impact of severe osteogenesis imperfecta on the lives of young patients and their parents—a qualitative analysis. BMC Pediatr 13:153. doi: 10.1186/1471-2431-13-153.:153-13 CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Rauch F, Lalic L, Roughley P, Glorieux FH (2010) Relationship between genotype and skeletal phenotype in children and adolescents with osteogenesis imperfecta. J Bone Miner Res 25:1367–1374PubMedGoogle Scholar
  19. 19.
    Hald JD, Folkestad L, Harslof T, Lund AM, Duno M, Jensen JB, Neghabat S, Brixen K, Langdahl B (2016) Skeletal phenotypes in adult patients with osteogenesis imperfecta-correlations with COL1A1/COL1A2 genotype and collagen structure. Osteoporos Int 27(11):3331–3341CrossRefPubMedGoogle Scholar
  20. 20.
    Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. conceptual framework and item selection. Med Care 30:473–483CrossRefPubMedGoogle Scholar
  21. 21.
    Ware JE Jr, Kosinski M, Bayliss MS, McHorney CA, Rogers WH, Raczek A (1995) Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study. Med Care 33:AS264–AS279CrossRefPubMedGoogle Scholar
  22. 22.
    Bjorner JB, Thunedborg K, Kristensen TS, Modvig J, Bech P (1998) The Danish SF-36 Health Survey: translation and preliminary validity studies. J Clin Epidemiol 51:991–999CrossRefPubMedGoogle Scholar
  23. 23.
    Bjorner JB, Damsgaard MT, Watt T, Groenvold M (1998) Tests of data quality, scaling assumptions, and reliability of the Danish SF-36. J Clin Epidemiol 51:1001–1011CrossRefPubMedGoogle Scholar
  24. 24.
    Ablon J (2003) Personality and stereotype in osteogenesis imperfecta: behavioral phenotype or response to life’s hard challenges? Am J Med Genet A 122A:201–214CrossRefPubMedGoogle Scholar
  25. 25.
    Reite M, Davis K, Solomons C, Ott J (1972) Osteogenesis imperfecta: psychological function. Am J Psychiatry 128:1540–1546CrossRefPubMedGoogle Scholar
  26. 26.
    Ose D, Rochon J, Campbell SM, Wensing M, Freund T, van LJ, Langst G, Szecsenyi J, Ludt S (2014) Health-related quality of life and risk factor control: the importance of educational level in prevention of cardiovascular diseases. Eur J Public Health 24:679–684CrossRefPubMedGoogle Scholar
  27. 27.
    de Putter CE, Selles RW, Haagsma JA, Polinder S, Panneman MJ, Hovius SE, Burdorf A, van Beeck EF (2014) Health-related quality of life after upper extremity injuries and predictors for suboptimal outcome. Injury 45(11):1752–1758CrossRefPubMedGoogle Scholar
  28. 28.
    Peric’ S, Rakocevic-Stojanovic V, Stevic Z, Basta I, Pavlovic S, Vujanac V, Marjanovic L, Lavrnic D (2010) Health-related quality of life in patients with myotonic dystrophy type 1 and amyotrophic lateral sclerosis. Acta Neurol Belg 110:71–77PubMedGoogle Scholar
  29. 29.
    Al-Shehri AH, Taha AZ, Bahnassy AA, Salah M (2008) Health-related quality of life in type 2 diabetic patients. Ann Saudi Med 28:352–360CrossRefPubMedGoogle Scholar
  30. 30.
    van der Slot WM, Nieuwenhuijsen C, van den Berg-Emons RJ, Wensink-Boonstra AE, Stam HJ, Roebroeck ME (2010) Participation and health-related quality of life in adults with spastic bilateral cerebral palsy and the role of self-efficacy. J Rehabil Med 42:528–535CrossRefPubMedGoogle Scholar
  31. 31.
    Bertoletti J, Marx GC, Hattge Junior SP, Pellanda LC (2014) Quality of life and congenital heart disease in childhood and adolescence. Arq Bras Cardiol 102:192–198PubMedPubMedCentralGoogle Scholar
  32. 32.
    Albrecht GL, Devlieger PJ (1999) The disability paradox: high quality of life against all odds. Soc Sci Med 48:977–988CrossRefPubMedGoogle Scholar
  33. 33.
    Bandura A (2004) Health promotion by social cognitive means. Health Educ Behav 31:143–164CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2017

Authors and Affiliations

  • Jannie Dahl Hald
    • 1
  • Lars Folkestad
    • 2
    • 3
    • 4
  • Torben Harsløf
    • 1
  • Kim Brixen
    • 3
  • Bente Langdahl
    • 1
  1. 1.Department of Endocrinology and Internal MedicineAarhus University HospitalAarhusDenmark
  2. 2.Department of EndocrinologyOdense University HospitalOdenseDenmark
  3. 3.Institute of Clinical ResearchUniversity of Southern DenmarkOdenseDenmark
  4. 4.Department of EndocrinologyHospital of Southwest DenmarkEsbjergDenmark

Personalised recommendations